Cassidi Voices Warning from ACIP voting on the HEP B vaccine
Senator Bill Cassidy (R-La) warned of the risk of hepatitis B in infants on Wednesday, before a Federal Vaccine Consultative Committee met with which changes are expected to discuss and vote for the current fortification schedule for the virus.
Cassidy, Chairman of the Senate on Health, Education, Labor, and pensions, said during his closing statements in a hearing with leaders of previous centers to control diseases and prevent them, against a recommendation that no longer chasing births against hepatitis BBB.
The ACIP consulting committee is scheduled to discuss at the Center for Disease Control and vote on hepatitis B vaccines on Thursday. The questions were not issued on the list.
“There is one thing that will be discussed at the upcoming ACIP meeting is to end the recommendation to obtain a dose of hepatitis B vaccine,” said Cassidy.
NPR reported on Tuesday doubts by former agency officials that ACIP plans to recommend the delay of hepatitis B.
“Why should the child be vaccinated due to a sexual intercourse when he is at birth? The child passes through the birth canal and is exposed to the same secretions of one otherwise,” Cassidy stated.
“This traffic through the birth channel makes this child vulnerable to the virus that is transmitted, not only hepatitis B, it can be HIV, can be other things,” continued. “But with regard to hepatitis B, this happens. If this child is infected at birth, more than 90 percent of them suffer from a chronic lifelong infection.”
He also indicated that hepatitis recklessly decreased by almost 70 percent after approval of the vaccine.
“Now, less than 20 children annually get hepatitis B from their mother. This is an achievement to make America healthy again.”
Cassidy, a liver specialist, often spoke to support vaccines against hepatitis B. During one of the assertions of the Minister of Health and Humanitarian Services, Robert F. Kennedy Junior, the Senator recalled a 18 -year -old patient who was suffering from hepatic failure caused by hepatitis B.
“Since then, I have been trying to do everything I can to make sure that I have never had to speak to a parent about the death of their child due to a preventive disease for the vaccine.”
After the hearing, the reporters were asked by Senator if the Americans should have confidence in changes in the recommendations of the hepatitis vaccine table B.
“No, because this data clearly shows that when the mother gives an option, this is not an authorization,” he answered.
“You give the mother the option, and if she has this option, she can choose to vaccinate her child,” Casidi continued. “We have shown that when I was quoted from data, I mean, we have decreased from 20,000 children annually in obtaining hepatitis B to 20 years. This is a significant decrease.”
If ACIP continues to recommend delaying hepatitis B vaccines, Cassidy recommends that parents speak with their doctors but maintained his belief that delay will exacerbate health.
“Of course, the challenge is that the insurance will not cover it, so it becomes financial hardship,” he said. “After that, I cannot answer it, because you must always balance the patient’s pocket book with its health.”
The legislator added: “Now, if the child is vaccinated at the age of four, probably and today, because of our success in preventing hepatitis B, the child will be fine, but I can promise you, there will be some hepatitis B.
